Advertisement

Anxiety

  • L. Kevin Chapman
  • Alphonso Nichols
Chapter

Abstract

Anxiety disorders are the most prevalent types of psychiatric disorders in the USA, affecting both children and adults at staggering rates. Moreover, roughly 25% of adolescents will be diagnosed with an anxiety disorder in his or her lifetime, suggesting that primary care physicians are more than likely to encounter these individuals on a frequent basis. Along these lines, it is imperative that primary care physicians recognize the symptomology endemic to anxiety and related disorders in children and adolescents. This chapter highlights the importance of recognizing the signs and symptoms of anxiety and related disorders in children and adolescents, differential diagnoses in children and adolescents, pharmacologic and behavioral interventions for managing anxiety and related symptoms, key measures available in assessing anxiety and related symptoms, and when to refer to other mental health providers.

Keywords

Anxiety disorders Separation anxiety Social anxiety Generalized anxiety Primary care Cognitive behavioral therapy CBT SSRIs SNRIs Benzodiazepines 

References

  1. 1.
    Chapman LK, Petrie J, Vines L, Durrett E. The co-occurrence of anxiety disorders in African American parents and their children. J Anxiety Disord. 2012;26(1):65–70.CrossRefGoogle Scholar
  2. 2.
    Greenburg PE, Tamar S, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psych. 1999;60(4):27–435.Google Scholar
  3. 3.
    Issakidis C, Sanderson K, Corry J, Andrews G, Lapsley H. Modeling the population cost-effectiveness of current and evidenced-based optimal treatment for anxiety disorders. Psych Med. 2004;34(1):19–35.CrossRefGoogle Scholar
  4. 4.
    Young AS, Klap R, Shoai R, Wells KB. Persistent depression and anxiety in the United States: prevalence and quality of care. Psychiatr Serv. 2008;59(12):1391–8.CrossRefGoogle Scholar
  5. 5.
    Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescents. Arch Gen Psychiatry. 2003;60:837–44.CrossRefGoogle Scholar
  6. 6.
    Kearney CA, Albano AM. When children refuse school: a cognitive-behavioral approach. Treatments that work. Oxford: Oxford University Press; 2007.CrossRefGoogle Scholar
  7. 7.
    Chapman LK, Kertz SJ, Zurlage MM, Woodruff-Borden J. A confirmatory factor analysis of specific phobia domains in African American and Caucasian American young adults. J Anxiety Disord. 2008;22(5):763–71.CrossRefGoogle Scholar
  8. 8.
    Chapman LK, Kertz SJ, Woodruff-Borden J. A structural equation model analysis of perceived control and psychological distress on worry among African American and European American young adults. J Anxiety Disord. 2009;23:69–76.CrossRefGoogle Scholar
  9. 9.
    Duperrouzel J, Hawes SW, Lopez-Quintero C, Pacheco-Colon I, Comer J, Gonzalez R. The association between adolescent cannabis use and anxiety: a parallel process analysis. Addict Behav. 2017;78:107–13.CrossRefGoogle Scholar
  10. 10.
    Martin A, Scahill L, Kratochvil CJ. Pediatric psychopharmacology. Principals and practice. Oxford: Oxford University Press; 2011. 38-49, 480-515.Google Scholar
  11. 11.
    Pagano M, Murphy JM, Pedersen M, et al. Screening for psychosocial problems in 4–5 year olds during routine EPSDT examinations: validity and reliability in a Mexican-American sample. Clin Pediatr. 1996;35(3):139–46.CrossRefGoogle Scholar
  12. 12.
    Kassam-Adams N. The acute stress checklist for children (ASC-Kids): development of a child self-report measure. J Trauma Stress. 2006;19(1):129–39.CrossRefGoogle Scholar
  13. 13.
    Chorpita BF, Tracey SA, Brown TA, Collica TJ, Barlow DH. Assessment of worry in children and adolescents: an adaptation of the Penn State Worry Questionnaire. Behav Res Ther. 1997;35(6):569–81.CrossRefGoogle Scholar
  14. 14.
    Chorpita BF, Yim LM, Moffitt CE, Umemoto LA, Francis SE. Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale. Behav Res Ther. 2000;38:835–55.CrossRefGoogle Scholar
  15. 15.
    Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M. Psychometric properties of the screen for child anxiety related emotional disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatr. 1999;38:1230–6.CrossRefGoogle Scholar
  16. 16.
    Spence SH. Structure of anxiety symptoms among children: a confirmatory factor-analytic study. J Abnorm Psych. 1997;106(2):280–97.CrossRefGoogle Scholar
  17. 17.
    Martin A, Volkmar FR. Lewis’s child and adolescent psychiatry, a comprehensive textbook. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 509–531,568.Google Scholar
  18. 18.
    Dulcan MK, editor. Depressive and disruptive mood dysregulation disorders. 2nd ed. Washington: American Psychiatric Association Publishing; 2016.Google Scholar
  19. 19.
    Birmaher B, Brent D. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1503–26.CrossRefGoogle Scholar
  20. 20.
    Martin A, Volkmar FR, Lewis M. Lewis’s child and adolescent psychiatry: a comprehensive textbook. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2007.Google Scholar
  21. 21.
    Labbate LAF, Maurizio R, Rosenbaum JF, Arana GW. Handbook of psychiatric drug therapy. Philadelphia: Lippincott Williams & Wilkins (LWW); 2009.Google Scholar
  22. 22.
    Valenstein M, Hyungjin M, et al. Antidepressant agents and suicide death among US Department of veterans affairs patients in depression treatment. J Clin Psychopharmacol. 2012;32(3):346–53.  https://doi.org/10.1097/JCP.0b013e3182539f11.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Mrakotsky C, Masek B, Biederman J, et al. prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia. J Anxiety Disord. 2008;22:88–97.CrossRefGoogle Scholar
  24. 24.
    Stawn JR, Mills JA, Cornwall GJ, Mossman SA, Varney ST, Keshin BR, Croaarkin PE. J Child Adolesc Psychopharmacol. 2018;28(1):2–9.  https://doi.org/10.1089/cap.2017.0060. Epub 2017 Aug 28.CrossRefGoogle Scholar
  25. 25.
    Cipriania A, Del Zhou X, Giovane C, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet. 2016;388(10047):881–90.  https://doi.org/10.1016/S0140-6736(16)30385-3. Epub 2016 Jun 8.CrossRefGoogle Scholar
  26. 26.
    Bernstein GA, Garfinkel BD, Borchardt CM. Comparative studies of pharmacotherapy for school refusal. J Am Acad Child Adolesc Psychiatry. 1990;29:773–81 [PubMed].CrossRefGoogle Scholar
  27. 27.
    Graae F, Milner J, Rizzotto L, et al. Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry. 1994;33:372–6 [PubMed].CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • L. Kevin Chapman
    • 1
  • Alphonso Nichols
    • 1
  1. 1.Independent PracticeLouisvilleUSA

Personalised recommendations